MRPL42 antibody
Principal name
MRPL42 antibody
Alternative names for MRPL42 antibody
L42mt, MRP-L42, MRP-L31, MRPL31, MRPS32, RPML31, HSPC204, PTD007, 28S ribosomal protein L42, mitochondrial, 28S ribosomal protein S32, mitochondrial
Ncbi ID
9606, NP_054769.1, NP_054769, NP_080341.1, NM_026065, NM_172177, NM_014050, NM_172178
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of MRPL42 antibody
- Kit Component:
- - KN310350G1, D10Ertd322e gRNA vector 1 in pCas-Guide vector
- KN310350G2, D10Ertd322e gRNA vector 2 in pCas-Guide vector
- KN310350D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of MRPL42 expression in transfected 293T cell line (H00028977-T01) by MRPL42 MaxPab polyclonal antibody.Lane 1: MRPL42 transfected lysate(15.62 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of MRPL42 expression in transfected 293T cell line (H00028977-T01) by MRPL42 MaxPab polyclonal antibody.Lane 1: MRPL42 transfected lysate(15.62 KDa).Lane 2: Non-transfected lysate.
Immunohistochemistry analysis of paraffin-embedded human placenta tissue using MRPS32 antibody.The picture on the right is treated with the synthesized peptide.
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP319175 | MRPL42 (transcript variant 1) |
||||
| Recombinant protein of human mitochondrial ribosomal protein L42 (MRPL42), nuclear gene encoding mitochondrial protein, transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
